SCHEMBL3860853

SCHEMBL3860853

CC(=O)C(c1ccccc1)(c1ccccc1)N1CCN(C(c2ccccc2)c2cccs2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.51
▸ OPRD1 P41143 2/20 0.51
▸ OPRK1 P41145 2/20 0.51
▸ OPRL1 P41146 2/20 0.51
▸ SLC6A9 P48067 2/20 0.48
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ DRD3 P35462 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026265 0.86 KMT2A (0.59) OPRM1OPRD1KMT2AMEN1ALDH1A1
SCHEMBL4185164 0.80 KCNH2 (0.57) OPRM1OPRK1KMT2AMEN1ALDH1A1
SCHEMBL5026280 0.76 HRH3 (0.44) KMT2AALDH1A1CYP2D6CHRM1KCNH2
SCHEMBL5027779 0.72 CACNA2D1 (0.73) CACNA1ACACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL13597052 0.67 OPRM1 (0.50) OPRM1OPRD1OPRK1OPRL1SLC6A9
Cyclizine SCHEMBL5656056 0.66 CYP2D6 (0.82) OPRM1OPRD1OPRK1KMT2AMEN1
SCHEMBL27404587 0.65 MAOB (0.50) OPRM1OPRD1OPRK1OPRL1KMT2A
SCHEMBL4669298 0.65 OPRM1 (0.58) OPRM1OPRD1OPRK1OPRL1KMT2A
SCHEMBL5027734 0.64 USP2 (0.50) KMT2AMEN1ALDH1A1CYP3A4CYP2C9
SCHEMBL9327563 0.64 ALDH1A1 (0.71) KMT2AMEN1ALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670775-A4 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD (CA) 2009-04-22 — — EP claimed
JP-2007504174-A — — 2007-03-01 — — JP claimed
EP-1670775-A1 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2006-06-21 — — EP claimed
WO-2005021523-A1 PIPERAZINE SUBSTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED TECHNOLOGIES, INC. (CA) 2005-03-10 — — WO claimed
Send feedback